Continuing Care App for Probationers and Parolees

Sponsor
COG Analytics (Other)
Overall Status
Recruiting
CT.gov ID
NCT04574193
Collaborator
Friends Research Institute, Inc. (Other)
100
1
2
11
9.1

Study Details

Study Description

Brief Summary

This project extends successful Phase I work that developed a Continuing Care mobile application (app) for probationers and parolees with SUDs who are at elevated risk of relapse, re-arrest, and incarceration. This Phase II STTR project will finalize app development and evaluate its efficacy in a randomized controlled trial. The project has high public health significance due to its potential to provide an accessible recovery support tool for individuals on probation or parole that could improve their substance use disorder treatment outcomes.

Condition or Disease Intervention/Treatment Phase
  • Device: digital therapeutic for substance use disorders
  • Other: Treatment As Usual
N/A

Detailed Description

Substance use disorders (SUDs) continue to be one of the most serious public health problems in the US. Studies have consistently documented a substantially higher prevalence of SUDs among adults under criminal justice supervision in the community (i.e., probation or parole) as compared to the general population. There is growing recognition that addiction is a chronic health condition, and individuals with SUDs typically cycle through multiple periods of treatment, abstinence, and relapse over several years to achieve and maintain recovery. Studies show that continuing care interventions can provide ongoing support or extend primary treatment gains with respect to reducing substance use, relapse, and criminal activity. Recent diffusion of Internet and smartphone technologies among disadvantaged populations now offers unprecedented opportunities for increasing access to quality continuing care interventions as well as chronic disease self-management tools. Probationers and parolees at high risk for drug abuse relapse and involvement in health compromising behaviors are an important population that stands to benefit from continuing care technologies. However, to date, no such technologies exist that are specifically tailored to meet the unique needs of this high-risk population.

Building on our team's extensive experience in the fields of criminology and substance use, we propose to complete the development of a Continuing Care mobile application (app) and conduct a randomized controlled trial to assess efficacy among clients on probation or parole who are enrolled in outpatient substance use treatment. The app is designed to meet the recovery and personal support needs of probationers and parolees with SUDs who are at elevated risk of relapse, re-arrest, and incarceration. It is guided by the principles of the transtheoretical model of behavior change and app content is derived from the Your Own Reintegration System (YOURS) program, an empirically-supported16 intervention that focuses on substance use recovery, reducing criminal thinking and behavior, and managing and building support systems. If proven to be efficacious, the app could be deployed across the national network of outpatient treatment providers, and be highly significant in its direct impact on public health.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The evaluation will involve a two-group RCT in which 100 men and women on probation or parole, who are currently receiving outpatient substance use treatment at THC, will be randomly assigned to one of two conditions: (1) Continuing Care app (CC app; n=50): Participants will receive the CC app, in addition to usual care at the treatment program (12-weeks of weekly group cognitive behavioral therapy), or (2) Treatment As Usual (TAU; n=50): Participants will only receive 12-weeks of weekly group cognitive behavioral therapy.The evaluation will involve a two-group RCT in which 100 men and women on probation or parole, who are currently receiving outpatient substance use treatment at THC, will be randomly assigned to one of two conditions: (1) Continuing Care app (CC app; n=50): Participants will receive the CC app, in addition to usual care at the treatment program (12-weeks of weekly group cognitive behavioral therapy), or (2) Treatment As Usual (TAU; n=50): Participants will only receive 12-weeks of weekly group cognitive behavioral therapy.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Continuing Care App for Probationers and Parolees With Substance Use Disorders
Actual Study Start Date :
Mar 8, 2021
Anticipated Primary Completion Date :
Feb 5, 2022
Anticipated Study Completion Date :
Feb 5, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Continuing Care App

Participants will receive the Continuing Care app, in addition to usual care at the treatment program (12-weeks of weekly group cognitive behavioral therapy).

Device: digital therapeutic for substance use disorders
The Continuing Care application (app) is a HIPAA-compliant, mobile-friendly, software program designed to meet the recovery and personal support needs of probationers and parolees with SUDs who are at elevated risk of relapse, re-arrest, and incarceration.

Active Comparator: Treatment As Usual

Participants will only receive 12-weeks of weekly group cognitive behavioral therapy.

Other: Treatment As Usual
12-weeks of weekly group cognitive behavioral therapy

Outcome Measures

Primary Outcome Measures

  1. Weeks Retained in Substance Use Treatment [up to 12 weeks]

    Number of weeks retained in treatment based on a review of clinical records

Secondary Outcome Measures

  1. Completion of Substance Use Treatment [up to 12 weeks]

    Treatment completed (yes or no) based on a review of clinical records

  2. Days of Substance Use [up to 18 weeks]

    Number of days of drug use based on self-report drug use and urine drug screen results

  3. Days of Criminal Activity; Re-arrest; Incarceration [up to 18 weeks]

    Number of crime days; re-arrest (yes or not); incarceration (yes or no) based on self-report information and public court record databases

Other Outcome Measures

  1. Rating of App Satisfaction [up to 12 weeks]

    Rating of client satisfaction using the app based on self-report information

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age 18 or older

  • Currently on community supervision (probation or parole) or justice-involvement in the past 12 months

  • Currently a client receiving outpatient substance use treatment

  • Willing to receive supplemental treatment services through a mobile app

  • Willing to provide informed consent and complete research assessments

Exclusion Criteria:
  • Severe psychiatric problems (e.g., untreated psychosis, untreated bipolar disorder)

  • Suicidality within the past 6-months, as determined by clinical staff, which could make participation in a novel treatment hazardous

Contacts and Locations

Locations

Site City State Country Postal Code
1 REACH Health Services Baltimore Maryland United States 21218

Sponsors and Collaborators

  • COG Analytics
  • Friends Research Institute, Inc.

Investigators

  • Principal Investigator: Steven B Carswell, Ph.D., COG Analytics

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Steven Carswell, Principal Investigator, COG Analytics
ClinicalTrials.gov Identifier:
NCT04574193
Other Study ID Numbers:
  • 2R44MD008848-02
First Posted:
Oct 5, 2020
Last Update Posted:
Aug 9, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 9, 2021